Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Silent cerebral events as a result of left atrial catheter ablation do not cause neuropsychological sequelae-a MRI-controlled multicenter study.

von Bary C, Deneke T, Arentz T, Schade A, Lehrmann H, Eissnert C, Schwab-Malek S, Fredersdorf S, Ücer E, Baldaranov D, Wendl C, Schlachetzki F.

J Interv Card Electrophysiol. 2015 Apr 29. [Epub ahead of print]

PMID:
25921346
2.

Unmasking the dormant pulmonary vein conduction with adenosine administration after pulmonary vein isolation with laser energy.

Üçer E, Fredersdorf S, Jungbauer CG, Seegers J, Debl K, Riegger G, Maier LS.

Europace. 2015 Mar 10. pii: euu368. [Epub ahead of print]

PMID:
25759410
3.

A unique access for the ablation catheter to treat electrical storm in a patient with extracorporeal life support.

Ücer E, Fredersdorf S, Jungbauer C, Debl K, Philipp A, Amann M, Holzamer A, Keyser A, Hilker M, Luchner A, Schmid C, Riegger G, Endemann D.

Europace. 2014 Feb;16(2):299-302. doi: 10.1093/europace/eut165. Epub 2013 Jun 30.

4.

Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation.

Fredersdorf S, Ucer E, Jungbauer C, Dornia C, Eglmeier J, Eissnert C, Hamer OW, Weber S, Arzt M, von Bary C.

Europace. 2014 Jan;16(1):26-32. doi: 10.1093/europace/eut152. Epub 2013 Jun 5.

5.

Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data.

Fredersdorf S, Thumann C, Zimmermann WH, Vetter R, Graf T, Luchner A, Riegger GA, Schunkert H, Eschenhagen T, Weil J.

Cardiovasc Diabetol. 2012 May 23;11:57.

6.

Differential expression of potassium channels and abnormal conduction in experimental tachycardia-induced heart failure.

Birner C, Husser O, Jeron A, Rihm M, Fredersdorf S, Resch M, Schmid P, Endemann D, Riegger G, Luchner A.

Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):473-80. doi: 10.1007/s00210-011-0723-x. Epub 2012 Feb 7.

PMID:
22311348
7.

Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report.

Resch M, Schmid P, Amann K, Fredersdorf S, Weil J, Schach C, Birner C, Griese DP, Kreuzer P, Brunner S, Luchner A, Riegger GA, Endemann DH.

Cardiovasc Diabetol. 2011 Oct 18;10:94. doi: 10.1186/1475-2840-10-94.

8.

Evaluation of pulmonary vein stenosis after pulmonary vein isolation using a novel circular mapping and ablation catheter (PVAC).

von Bary C, Weber S, Dornia C, Eissnert C, Fellner C, Latzin P, Fredersdorf S, Stadler S, Hamer OW.

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):630-6. doi: 10.1161/CIRCEP.111.963397. Epub 2011 Aug 13.

9.

Reversible complete heart block in ANCA-associated vasculitis.

Reinhard W, Kallmuenzer B, Bergua A, Fleck M, Luchner A, Riegger G, Fredersdorf S.

Clin Res Cardiol. 2011 Jan;100(1):93-5. doi: 10.1007/s00392-010-0234-7. Epub 2010 Sep 21. No abstract available.

PMID:
20857124
10.

Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure.

Resch M, Bergler T, Fredersdorf S, Griese DP, Weil J, Kreuzer P, Brunner S, Riegger GA, Luchner A, Endemann DH.

Hypertens Res. 2010 Oct;33(10):1082-8. doi: 10.1038/hr.2010.132. Epub 2010 Jul 22.

PMID:
20664544
11.

Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.

Buchner S, Debl K, Barlage S, Griese D, Fredersdorf S, Jeron A, Lubnow M, Müller T, Muders F, Holmer S, Riegger GA, Luchner A.

Clin Chem Lab Med. 2010 Jun;48(6):875-81. doi: 10.1515/CCLM.2010.164.

PMID:
20441480
12.

First-in-man (FIM) experience with the Magnetic Medical Positioning System (MPS) for intracoronary navigation.

Jeron A, Fredersdorf S, Debl K, Oren E, Izmirli A, Peleg A, Nekovar A, Herscovici A, Riegger GA, Luchner A.

EuroIntervention. 2009 Nov;5(5):552-7.

PMID:
20142175
13.

Defibrillator implantation early after myocardial infarction.

Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgärtner F, Lubinski A, Rosenqvist M, Habets A, Wegscheider K, Senges J; IRIS Investigators.

N Engl J Med. 2009 Oct 8;361(15):1427-36. doi: 10.1056/NEJMoa0901889.

14.

Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.

Resch M, Wiest R, Moleda L, Fredersdorf S, Stoelcker B, Schroeder JA, Schölmerich J, Endemann DH.

Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G849-57. doi: 10.1152/ajpgi.00084.2009. Epub 2009 Aug 20.

15.

Safe and rapid isolation of pulmonary veins using a novel circular ablation catheter and duty-cycled RF generator.

Fredersdorf S, Weber S, Jilek C, Heinicke N, VON Bary C, Jungbauer C, Riegger GA, Hamer OW, Jeron A.

J Cardiovasc Electrophysiol. 2009 Oct;20(10):1097-101. doi: 10.1111/j.1540-8167.2009.01501.x. Epub 2009 Jun 1.

PMID:
19493155
16.

Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure.

Schneider HJ, Husser O, Rihm M, Fredersdorf S, Birner C, Dhein S, Muders F, Jeron A, Goegelein H, Riegger GA, Luchner A.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):225-32. doi: 10.1007/s00210-008-0361-0. Epub 2008 Oct 30.

PMID:
18972103
17.

Increased aldosterone levels in a model of type 2 diabetes mellitus.

Fredersdorf S, Endemann DH, Luchner A, Heitzmann D, Ulucan C, Birner C, Schmid P, Stoelcker B, Resch M, Muders F, Riegger GA, Weil J.

Exp Clin Endocrinol Diabetes. 2009 Jan;117(1):15-20. doi: 10.1055/s-2008-1073128. Epub 2008 Aug 25.

PMID:
18726873
18.

Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.

Birner CM, Ulucan C, Fredersdorf S, Rihm M, Löwel H, Stritzke J, Schunkert H, Hengstenberg C, Holmer S, Riegger G, Luchner A.

Cytokine. 2007 Nov;40(2):89-97. Epub 2007 Oct 24.

PMID:
17920926
19.

Assessment of the anatomic regurgitant orifice in aortic regurgitation: a clinical magnetic resonance imaging study.

Debl K, Djavidani B, Buchner S, Heinicke N, Fredersdorf S, Haimerl J, Poschenrieder F, Feuerbach S, Riegger GA, Luchner A.

Heart. 2008 Mar;94(3):e8. Epub 2007 Aug 8.

PMID:
17686805
20.

Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats.

Fredersdorf S, Weil J, Ulucan C, Birner C, Büttner R, Schubert T, Böger CA, Debl K, Muders F, Riegger GA, Luchner A.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Apr;375(2):95-103. Epub 2007 Mar 1.

PMID:
17333128
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk